{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:29:35Z","timestamp":1791318575270,"version":"4.3.1"},"reference-count":31,"publisher":"Japan Atherosclerosis Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5551\/jat.14035","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T03:31:33Z","timestamp":1380079893000},"page":"878-892","source":"Crossref","is-referenced-by-count":38,"title":["Carbamylated-Oxidized LDL: Proatherosclerotic Effects on Endothelial Cells and Macrophages"],"prefix":"10.5551","volume":"20","author":[{"given":"Eugene","family":"O. Apostolov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercan","family":"Ok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Savenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"V. Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"G. Basnakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Nissenson AR, Pereira BJ, Collins AJ, Steinberg EP: Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. Am J Kidney Dis, 2001; 37: 1177-1183","DOI":"10.1053\/ajkd.2001.24520"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Galle J, Hansen-Hagge T, Wanner C, Seibold S: Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis, 2005","DOI":"10.1016\/j.atherosclerosis.2005.10.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Van Tits L, De Graaf J, Hak-Lemmers H, Bredie S, Demacker P, Holvoet P, Stalenhoef A: Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis. Lab Invest, 2003; 83: 13-21","DOI":"10.1097\/01.LAB.0000048633.76607.E0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Gonen B, Goldberg AP, Harter HR, Schonfeld G: Abnormal cell-interactive properties of low-density lipoproteins isolated from patients with chronic renal failure. Metabolism, 1985; 34: 10-14","DOI":"10.1016\/0026-0495(85)90052-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kraus LM, Kraus AP Jr: Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl, 2001; 78: S102-107","DOI":"10.1046\/j.1523-1755.2001.07811.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL: Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med, 2007; 13: 1176-1184","DOI":"10.1038\/nm1637"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Horkko S, Savolainen MJ, Kervinen K, Kesaniemi YA: Carbamylation-induced alterations in low-density lipoprotein metabolism. Kidney Int, 1992; 41: 1175-1181","DOI":"10.1038\/ki.1992.179"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Roxborough HE, Young IS: Carbamylation of proteins and atherogenesis in renal failure. Med Hypotheses, 1995; 45: 125-128","DOI":"10.1016\/0306-9877(95)90059-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Apostolov EO, Shah SV, Ok E, Basnakian AG: Quantification of carbamylated LDL in human sera by a new sandwich ELISA. Clin Chem, 2005; 51: 719-728","DOI":"10.1373\/clinchem.2004.044032"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Apostolov EO, Shah SV, Ok E, Basnakian AG: Carbamylated low-density lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol, 2007; 27: 826-832","DOI":"10.1161\/01.ATV.0000258795.75121.8a"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ok E, Basnakian AG, Apostolov EO, Barri YM, Shah SV: Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int, 2005; 68: 173-178","DOI":"10.1111\/j.1523-1755.2005.00391.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Apostolov EO, Basnakian AG, Yin X, Ok E, Shah SV: Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway. Am J Physiol Heart Circ Physiol, 2007; 292: H1836-1846","DOI":"10.1152\/ajpheart.01079.2006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Apostolov EO, Ray D, Alobuia WM, Mikhailova MV, Wang X, Basnakian AG, Shah SV: Endonuclease G mediates endothelial cell death induced by carbamylated LDL. Am J Physiol Heart Circ Physiol, 2011; 300: H1997-2004","DOI":"10.1152\/ajpheart.01311.2010"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Apostolov EO, Shah SV, Ray D, Basnakian AG: Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL. Arterioscler Thromb Vasc Biol, 2009; 29: 1622-1630","DOI":"10.1161\/ATVBAHA.109.189795"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Carracedo J, Merino A, Briceno C, Soriano S, Buendia P, Calleros L, Rodriguez M, Martin-Malo A, Aljama P, Ramirez R: Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. Faseb J, 2011; 25: 1314-1322","DOI":"10.1096\/fj.10-173377"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Apostolov EO, Ray D, Savenka AV, Shah SV, Basnakian AG: Chronic Uremia Stimulates LDL Carbamylation and Atherosclerosis. J Am Soc Nephrol, 2010; 21: 1852-1857","DOI":"10.1681\/ASN.2010040365"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Jaisson S, Pietrement C, Gillery P: Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis. Clin Chem, 2011; 57: 1499-1505","DOI":"10.1373\/clinchem.2011.163188"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Zhao W, Varghese M, Yemul S, Pan Y, Cheng A, Marano P, Hassan S, Vempati P, Chen F, Qian X, Pasinetti GM: Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1alpha) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Mol Neurodegener, 2011; 6: 51","DOI":"10.1186\/1750-1326-6-51"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Lazarenko OP, Rzonca SO, Suva LJ, Lecka-Czernik B: Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat. Bone, 2006; 38: 74-84","DOI":"10.1016\/j.bone.2005.07.008"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Basnakian AG, Shah SV, Ok E, Altunel E, Apostolov EO: Carbamylated LDL. Adv Clin Chem, 2010; 51: 25-52","DOI":"10.1016\/S0065-2423(10)51002-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Lam MC, Tan KC, Lam KS: Glycoxidized low-density lipoprotein regulates the expression of scavenger receptors in THP-1 macrophages. Atherosclerosis, 2004; 177: 313-320","DOI":"10.1016\/j.atherosclerosis.2004.08.003"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) de Villiers WJ, Smart EJ: Macrophage scavenger receptors and foam cell formation. J Leukoc Biol, 1999; 66: 740-746","DOI":"10.1002\/jlb.66.5.740"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Sakata N, Uesugi N, Takebayashi S, Nagai R, Jono T, Horiuchi S, Takeya M, Itabe H, Takano T, Myint T, Taniguchi N: Glycoxidation and lipid peroxidation of lowdensity lipoprotein can synergistically enhance atherogenesis. Cardiovasc Res, 2001; 49: 466-475","DOI":"10.1016\/S0008-6363(00)00262-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Chiu JH, Peng YN, Yang YL, Tsai MH, Ho YL, Wu CY, Liu MY: In vitro oxidized and glycated human low-density lipoprotein particles characterized by capillary zone electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci, 2008; 875: 383-391","DOI":"10.1016\/j.jchromb.2008.09.014"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Boullier A, Bird DA, Chang MK, Dennis EA, Friedman P, Gillotre-Taylor K, Horkko S, Palinski W, Quehenberger O, Shaw P, Steinberg D, Terpstra V, Witztum JL: Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci, 2001; 947: 214-222; discussion 222-213","DOI":"10.1111\/j.1749-6632.2001.tb03943.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Avogaro P, Bon GB, Cazzolato G: Presence of a modified low density lipoprotein in humans. Arteriosclerosis, 1988; 8: 79-87","DOI":"10.1161\/01.ATV.8.1.79"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Orso E, Grandl M, Schmitz G: Oxidized LDL-induced endolysosomal phospholipidosis and enzymatically modified LDL-induced foam cell formation determine specific lipid species modulation in human macrophages. Chem Phys Lipids, 2011; 164: 479-487","DOI":"10.1016\/j.chemphyslip.2011.06.001"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Shashkin P, Dragulev B, Ley K: Macrophage differentiation to foam cells. Curr Pharm Des, 2005; 11: 3061-3072","DOI":"10.2174\/1381612054865064"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nicholson AC, Febbraio M, Han J, Silverstein RL, Hajjar DP: CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor. Ann N Y Acad Sci, 2000; 902: 128-131; discussion 131-123","DOI":"10.1111\/j.1749-6632.2000.tb06307.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Hegyi L, Skepper JN, Cary NR, Mitchinson MJ: Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol, 1996; 180: 423-429","DOI":"10.1002\/(SICI)1096-9896(199612)180:4<423::AID-PATH677>3.0.CO;2-1"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Martinet W, Kockx MM: Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation. Curr Opin Lipidol, 2001; 12: 535-541","DOI":"10.1097\/00041433-200110000-00009"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T18:42:48Z","timestamp":1621536168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/20\/12\/20_14035\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.14035","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}